Business Description
Provention Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US74374N1028
Description
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-101.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.9 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 8.68 | |||||
| Beneish M-Score | 3.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -15.3 | |||||
| 3-Year EPS without NRI Growth Rate | -12.8 | |||||
| 3-Year FCF Growth Rate | -4.8 | |||||
| 3-Year Book Growth Rate | -6.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 269.6 | |||||
| 12-1 Month Momentum % | 379.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.93 | |||||
| Quick Ratio | 1.92 | |||||
| Cash Ratio | 1.83 | |||||
| Days Sales Outstanding | 38.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.5 | |||||
| Shareholder Yield % | -1.25 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -993.88 | |||||
| Net Margin % | -880.69 | |||||
| FCF Margin % | -584.78 | |||||
| ROE % | -103.2 | |||||
| ROA % | -71.59 | |||||
| ROIC % | -269.16 | |||||
| ROC (Joel Greenblatt) % | -5338.77 | |||||
| ROCE % | -104.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 162.21 | |||||
| PB Ratio | 17.97 | |||||
| Price-to-Tangible-Book | 35.18 | |||||
| EV-to-EBIT | -17.65 | |||||
| EV-to-Forward-EBIT | -14.98 | |||||
| EV-to-EBITDA | -17.83 | |||||
| EV-to-Revenue | 172.67 | |||||
| EV-to-Forward-Revenue | 44.22 | |||||
| EV-to-FCF | -29.53 | |||||
| Price-to-Net-Current-Asset-Value | 36.74 | |||||
| Price-to-Net-Cash | 43.82 | |||||
| Earnings Yield (Greenblatt) % | -5.67 | |||||
| FCF Yield % | -4.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Provention Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.895 | ||
| EPS (TTM) ($) | -1.53 | ||
| Beta | 0 | ||
| Volatility % | 203.6 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.198929 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 379.48 | ||
| 52-Week Range ($) | 3.185 - 25 | ||
| Shares Outstanding (Mil) | 94.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Provention Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Provention Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Provention Bio Inc Frequently Asked Questions
What is Provention Bio Inc(PRVB)'s stock price today?
The current price of PRVB is $24.98. The 52 week high of PRVB is $25.00 and 52 week low is $3.19.
When is next earnings date of Provention Bio Inc(PRVB)?
The next earnings date of Provention Bio Inc(PRVB) is 2025-03-15 Est..
Does Provention Bio Inc(PRVB) pay dividends? If so, how much?
Provention Bio Inc(PRVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers